Device Sectors
New 3-D imaging techniques for improved lung cancer drug development
July 7, 2010 12:32 pm | by EurekAlert | News | Comments(Optical Society of America) Advanced imaging technologies that promise to improve effective drug development to treat lung cancer are the focus of the current issue of Optics Express, an open-access journal published by the Optical Society. Research outlines standardized...
ESC Congress 2010: The year's major event in cardiovascular medicine
July 7, 2010 12:32 pm | by EurekAlert | News | Comments(European Society of Cardiology) The European Society of Cardiology Congress 2010, the world's biggest international meeting in Cardiology will be held in Stockholm, Sweden, from Aug. 28-Sept. 1, 2010.The scientific program for this year's ESC Congress is now complete and promises...
FDA Launches Medical Device and Radiation-Emitting Product Transparency Website
July 7, 2010 11:34 am | Product Releases | CommentsThe FDA launched the Center for Devices and Radiological Health (CDRH) Transparency website as part of the agency’s transparency initiative.
Department of Defense Funding Shows Continued and Bi-Partisan Support for STB® Lifesaving Technologies' Products to Stop Blood Loss
July 7, 2010 11:33 am | by Bio-Medicine.Org | News | CommentsROCKVILLE, Md. , July 7 /- For the third consecutive year the Department of Defense demonstrated its commitment to help save the lives of our troops by providing STB Lifesaving Technologies® with $2.85 million of funding. The award is to further advance the development of STB®'s...
InnerPulse to Utilize Realistic Simulation from Dassault Systèmes
July 7, 2010 11:07 am | Product Releases | CommentsSudden cardiac death (SCD) remains a major threat despite advances in medication and other treatments. According to the Sudden Cardiac Arrest Association, approximately one American life is lost every two minutes and it has been estimated that SCD claims more than 7,000,000 lives per year worldwide–the overwhelming majority of those deaths are caused by ventricular fibrillation, or rapid, uncoordinated contractions.
Alnylam launches drug trial to treat rare disease
July 7, 2010 10:35 am | by Mass High Tech: The Journal of New England Technology | News | CommentsAlnylam Pharmaceuticals Inc. has launched a Phase 1 trial for a drug candidate targeting a rare disease known as ATTR. Investors and analysts are taking notice because it is one of just a handful of RNAi human trials ongoing.
Cancer deaths continue to drop
July 7, 2010 10:34 am | by EurekAlert | News | Comments(American Cancer Society) The continued drop in overall cancer mortality rates over the last 20 years has averted more than 767,000 cancer deaths according to a new report from the American Cancer Society.
Testing Defibrillation-Proof Circuits of Medical Products Simplified
July 7, 2010 10:20 am | Compliance West USA | Product Releases | CommentsThe MegaPulse Defib-5 is a simple, fast, easy-to-use tester designed to test defibrillation-proof circuits of medical products as required by the IEC. It has been updated to the requirements of IEC 60601-1:2005, EC-13, and others.
Avnet Electronics Marketing at the Medical Design West Show
July 7, 2010 9:31 am | by BusinessWire | Videos | CommentsVideo: Business Wire
Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules
July 7, 2010 8:35 am | by Bio-Medicine.Org | News | CommentsJERUSALEM, Israel , July 7, 2010 /- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement (MSA) with sanofi-aventis. According to the MSA, sanofi-aventis will...
Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
July 7, 2010 8:35 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina http://www.reportlinker.com/p0186217/Stakeholder-Opinions-Vaccines-in...
Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
July 7, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity http://www.reportlinker.com/p0...
Renhuang Begins Trading on NYSE Amex
July 7, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsHARBIN, China , July 7 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (NYSE Amex: CBP ) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that,...
Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant
July 7, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsSOMERVILLE, N.J. , July 7 /- Ethicon, Inc., a worldwide leader in surgical care, announced today the introduction of ETHICON™ OMNEX™ Surgical Sealant, ETHICON™ Biosurgery's first synthetic sealant designed to achieve adjunctive hemostasis (stoppage of bleeding) in...
Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas
July 7, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsCINCINNATI , July 7 /PRNewswire-USNewswire/ -- Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice – still an elusive goal when treating humans with cancer, according...
Hospital study suggests that early transfusion increases acute upper GI re-bleeding risk
July 7, 2010 7:34 am | by EurekAlert | News | Comments(Wiley-Blackwell) Doctors have called for an urgent review of transfusion policies after a UK-wide study of 221 hospitals found that patients admitted with acute upper gastrointestinal bleeding are more than twice as likely to suffer further bleeding if they receive a red blood...
Zweena Selects ITelagen to Host Personal Health Records Application
July 7, 2010 5:35 am | by Bio-Medicine.Org | News | CommentsWEST WINDSOR, N.J. , July 7 /- ITelagen, a leading provider of electronic health record (EHR) hosting and management announced that it was selected by Zweena, LLC of West Windsor, NJ to host their Zweena Health Record, personal health record application. ITelagen, which was selected for...
Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
July 7, 2010 5:34 am | by Bio-Medicine.Org | News | CommentsBEIJING , July 7 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC"), today announced it will present at the...
Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
July 7, 2010 5:34 am | by Bio-Medicine.Org | News | CommentsEAST NORRITON, Pa. , July 7 /- Tengion Inc. (Nasdaq: TNGN ) today announced that it has appointed Sunita B. Sheth , M.D., to the position of Chief Medical Officer, Vice President, Clinical and Regulatory Affairs. In this role, Dr. Sheth will be responsible for developing clinical...
Nile Therapeutics Completes Dosing of Phase II Study
July 7, 2010 4:36 am | by Bio-Medicine.Org | News | CommentsSAN FRANCISCO , July 7 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an...
Concord Medical Files 2009 Annual Report on Form 20-F
July 7, 2010 4:34 am | by Bio-Medicine.Org | News | CommentsBEIJING , July 7 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), operator of the largest network of radiotherapy and diagnostic imaging centers in China , today announced that it has filed its annual report for...
Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver
July 7, 2010 4:34 am | by Bio-Medicine.Org | News | CommentsDENVER , July 7 /- Invision Sally Jobe is among the first diagnostic imaging networks in the nation to offer a new breast ultrasound technology for the early detection of cancer. Screening Breast Ultrasound (SBU) is a highly effective technology developed to complement mammography in...
Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial
July 6, 2010 7:34 pm | by Bio-Medicine.Org | News | CommentsMENLO PARK, Calif. , July 6 /- Crux Biomedical®Inc. announced today that it has successfully enrolled the first patient in its Retrieve 2 pivotal U.S. IDE trial. The trial will evaluate the safety and efficacy of Crux's new Vena Cava Filter (VCF). The Crux VCF is a retrievable,...
People With Disabilities Experience Their Possibilities at Abilities Expo Chicagoland
July 6, 2010 4:36 pm | by Bio-Medicine.Org | News | CommentsCHICAGO , July 6 /- Thousands of people with disabilities, their families, caregivers, seniors, veterans and healthcare professionals are expected to attend Abilities Expo on Friday, July 9 , through Sunday, July 11, 2010 at the Schaumburg Convention Center. Admission is free and show...
Hologic buying Sentinelle Medical for $85M
July 6, 2010 4:35 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsHologic Inc., the Bedford-based supplier of diagnostic tools for women, announced today that it has reached an agreement to buy Sentinelle Medical Inc., a privately-held Toronto company, for $85 million.
